 this is a question for Joey Jacobs, our chairman and chief executive officer of Acadia Healthcare. in the fourth quarter of 2016, we added 967 beds to the company, including 670 beds that we added in 2015 and 6 new facilities that we added in the same period. on a constant currency basis, our revenue for the fourth quarter of 2016 increased 41.9% to $702.9 million from $495.3 million for the fourth quarter of 2015. Adjusted income from continuing operations attributable to Acadia increased 21.4% to $51.3 million for the fourth quarter of 2016 and was $0.59 per diluted share for both, the fourth quarter of 2016 and 2015 on a 22.1% increase in weighted average diluted shares outstanding. Adjusted diluted EPS for the latest quarter excludes debt extinguishment costs of $842 million, a loss on divestiture of $4.1 million and transaction related expenses of $14.8 million. Comparable quarter consolidated adjusted EBITDA grew 33.7% to $149.5 million, which was 21.3% of consolidated revenue. 
 our operating cash flow from continuing operations increased 8.1% for the fourth quarter to $106.6 million, and for the full year, increased 53.5% to $371.7 million. 
 we also expect substantial ongoing cash flow from continuing operations, which totaled over $370 million for 2016. our guidance for 2017 includes the following, revenue in a range of $2.85 billion to $2.9 billion, adjusted EBITDA in a range of $625 million to $640 million and adjusted diluted EPS in a range of $2.40 to $2.50. 